![Michael Boennighausen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Boennighausen
Geen lopende functies
Profiel
Michael Boennighausen worked as the Chief Financial Officer at Conor Medsystems LLC from 2002 to 2009 and as the Director of Investor Relations at ALZA Corp.
He completed his undergraduate degree at Stanford University and earned an MBA from the University of California, Los Angeles.
Eerdere bekende functies van Michael Boennighausen
Bedrijven | Functie | Einde |
---|---|---|
ALZA CORPORATION | Public Communications Contact | - |
Conor Medsystems LLC
![]() Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Financieel Directeur/CFO | - |
Opleiding van Michael Boennighausen
Stanford University | Undergraduate Degree |
University of California, Los Angeles | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Conor Medsystems LLC
![]() Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
ALZA Corp.
![]() ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |